Abdul Mannan: APTT Mixing Studies Confuse a Lot of People
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
”APTT mixing studies confuse a lot of people.
Let me show you why the incubated step matters.
Factor VIII is thermally labile. At 37°C, it naturally decays over 1-2 hours.
This isn’t pathology—it’s normal biology.
But here’s the trick: this can look exactly like a time-dependent inhibitor if you’re not careful.
The solution? Run parallel tests.
Here’s what you need to know:
- Test both immediate AND incubated samples (at 2 hours)
- Compare patient plasma alone vs 1:1 mix with normal pooled plasma
- Normal thermal decay: slight drift in both NPP and 1:1 mix
- Time-dependent inhibitor: the 1:1 mix prolongs MORE than NPP control
- Golden rule: If Δ(1:1 Mix) > Δ(NPP Control), think inhibitor
The pattern tells the story.
Normal FVIII lability shows similar small shifts in both tubes.
A true inhibitor shows clearly more prolongation in the mix than the control—it’s time AND temperature dependent, not just thermal drift.
Pro tip: Always use properly buffered conditions (Nijmegen-modified) for stability.
Thaw plasma promptly at 37°C and test without delay for routine assays. If you’re uncertain, measure
FVIII:C before and after incubation.
What’s the most challenging APTT mixing study pattern you’ve interpreted recently?”
Stay updated with Hemostasis Today.
-
May 23, 2026, 02:26Muhammad Hashim: When the Blood Smear Told a Different Story Behind a ‘Critical’ Platelet Count
-
May 23, 2026, 02:20Augustina Isioma Ikusemoro: Understanding One of the Most Common and Preventable Transfusion Reactions
-
May 23, 2026, 02:15What’s Your Advice for the Newly Diagnosed? – ITP Support Association
-
May 23, 2026, 02:08Rob Maloney: When You Stop Building Only a Career and Start Building a Life of Significance
-
May 23, 2026, 02:04Rahmathullah S.N.: Key Takeaways on Successful Surgical Outcomes in Patients with Congenital Bleeding Disorders
-
May 23, 2026, 01:51Paula Greter: Access and Innovation in Hemophilia through ERAH2026
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection